论文部分内容阅读
目的研究分析米非司酮配合中药对子宫内膜异味症的疗效及对CA125水平的影响。方法抽选2013年10月-2015年10月医院收疗的子宫内膜异位症患者120例,随机分为试验组和对照组各60例,对照组口服米非司酮治疗,试验组应用米非司酮配合中药治疗,对2组治疗效果和CA125水平进行比较分析。结果试验组治疗总有效率高于对照组,CA125水平显著低于对照组,差异明显有统计学意义,均P<0.05。结论联合应用米非司酮和中药治疗子宫内膜异位症,有利于疗效的提高,有效降低机体CA125水平,值得临床推广应用。
Objective To study the curative effect of mifepristone and traditional Chinese medicine on endometrial dementia and its effect on the level of CA125. Methods Totally 120 patients with endometriosis who were hospitalized from October 2013 to October 2015 were randomly divided into experimental group and control group with 60 cases each. The control group was treated with mifepristone, and the experimental group was used Mifepristone with traditional Chinese medicine treatment, the two groups of therapeutic effect and CA125 levels were compared. Results The total effective rate of the experimental group was higher than that of the control group, the level of CA125 was significantly lower than that of the control group, the difference was statistically significant (P <0.05). Conclusions The combination of mifepristone and traditional Chinese medicine in the treatment of endometriosis is beneficial to the improvement of curative effect and effectively reducing the level of CA125 in the body, which is worthy of clinical application.